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Bust a move
Psoriasis is a multifactorial disease that stems from interactions 
between genetics and environmental risk factors. Increased 
body mass index is a risk factor for psoriasis, and overweight 
and obese individuals are more likely to have severe psoria-
sis. Not surprisingly, then, weight loss is associated with clini-
cal improvement of psoriasis in obese patients. Naldi and 
colleagues conducted a randomized controlled trial of 303 
patients to examine the effects of diet and exercise interven-
tion in combination with systemic treatment on psoriasis 
severity. The intervention significantly reduced disease 
severity beyond the effect of the systemic treatment after 20 
weeks. These results emphasize the usefulness of weight loss 
in obese patients as part of a holistic approach to combat 
both psoriasis and the associated comorbidities, and this 
information is particularly insightful in light of the currently 
increasing population of overweight and obese individuals. (Br 
J Dermatol 170:634–42, 2014) Selected by H. Williams
Adapters in inflammation
Although previous studies have revealed mutations in the IL-36 
receptor antagonist in individuals with the severe inflammatory 
skin disease pustular psoriasis (PP), the causative genetic muta-
tions are unknown for the majority of cases. Setta-Kaffetzi and 
colleagues identified two specific mutations (Phe47Cys and 
Arg33Trp) in the AP1S3 gene, which encodes the σ3 subunit 
of the adapter protein 1 (AP-1) complex, among 128 European 
and 76 non-European individuals with PP. Adapter proteins 
promote the assembly and trafficking of small transport vesicles 
and are therefore critical cellular factors. AP-1 is specifically 
involved in transport of cargo between the trans-Golgi and 
the endosome. Structural biology and overexpression experi-
ments suggested that these mutations are unfavorable for AP-1 
function. Because the mutants are thought to abrogate AP-1 
activity, these investigators showed that AP1S3 knockdown 
disrupted Toll-like receptor 3 endosomal translocation and 
consequently IFN-β expression. IFN-β is critical for downregu-
lating IL-1 production, which drives most autoinflammatory 
diseases, suggesting a direct link between these AP-1 mutations 
and increased inflammation in PP patients. (Am J Hum Genet 
94:790–7, 2014) Selected by J. Uitto
Let the sun shine
The incidence of multiple sclerosis (MS), an immune-mediated 
disorder of the central nervous system (CNS), increases 
with increasing distance from the equator, purportedly 
owing to effects on vitamin D levels and immune modula-
tion by UV radiation exposure. Using a mouse model of MS 
(experimental autoimmune encephalomyelitis), Breuer and 
colleagues recently demonstrated that UVB radiation influences 
immunoregulatory processes in the skin and that these effects 
can be transferred to other organs via induction of tolerogenic 
dendritic cells (DCs) and regulatory T cells (Tregs). Importantly, 
in a small human proof-of-concept clinical trial of MS patients, 
UVB radiation was found to increase numbers of Tregs and 
tolerogenic DCs and to downregulate the T-cell effector IL-21. 
Together, these findings link UVB radiation with systemic 
immune regulation and tolerance via induction of tolerogenic 
DCs and Tregs to connect cutaneous immune response to CNS 
immunity, highlighting the relevance of environmental factors 
in autoimmunity and further describing the skin–CNS axis. 
(Ann Neurol 75:739–58, 2014) Selected by T. Schwarz
Affinity alterations
In allergy, individuals produce IgE antibodies to allergy-
inducing antigens, and these antibodies bind via Fc to the 
FcεR1 on mast cells, which, upon antigen binding, causes 
clustering of the individual receptors and ultimately mast-
cell response. Undoubtedly, IgE antibodies exhibit different 
affinities for the antigen. To examine how the high-affinity IgE 
receptor FcεR1 discriminates between high- and low-affinity 
stimulation to appropriately modulate the mast-cell response, 
Suzuki and colleagues compared two different antigens, one 
with high affinity (DNP) and one with low affinity (2NP). 
Both stimuli resulted in similar receptor phosphorylation, 
but receptor cluster size, mobility, and distribution differed 
between the two. Interestingly, the cell effector responses 
also differed between these two antigen stimuli, and these 
differences were translated via qualitative changes in 
signaling, ultimately resulting in distinct outcomes. (Science 
343:1021–5, 2014) Selected by T. Biedermann
Drug-induced death by necroptosis
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis 
(TEN) are rare but life-threatening adverse drug reactions that 
involve extensive detachment of the epidermis via induction of 
an immunological reaction that results in keratinocyte death. 
Saito and colleagues recently demonstrated that this SJS/TEN 
keratinocyte death occurs by necroptosis, a programmed type 
of cell death that resembles both necrosis and apoptosis. Using 
mass spectrometry of supernatants of drug-exposed peripheral 
blood mononuclear cells, these investigators identified annex-
in A1 as a key mediator of keratinocyte death. Molecularly, 
the causative drug induces monocyte secretion of annexin A1, 
which then binds to and induces the formyl peptide receptor 
1 (FPR1) on keratinocytes, resulting in cellular death. In mice, 
treatment with the necroptosis inhibitor Nec-1 effectively 
inhibited drug-induced SJS/PTEN keratinocyte death, sup-
porting the notion that necroptosis underlies the rampant cell 
death in SJS/TEN. These results pave the way for development 
of a means to derail this dangerous immune reaction to oth-
erwise beneficial drugs. (Sci Transl Med 6:245ra95, 2014) 
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